Table 3.
Predictors of Spontaneous Bacterial Peritonitis in Patients Receiving SBP Prophylaxis.
| Variables | Primary prophylaxis |
Secondary prophylaxis |
||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis OR (95% CI) |
P-value | Multivariate analysis OR (95% CI) |
P-value | Univariate analysis OR (95% CI) |
P-value | Multivariate analysis OR (95% CI) |
P-value | |
| Age | 1.01 (0.96–1.07) | 0.5 | 0.97 (0.92–1.01) | 0.2 | ||||
| Serum albumin | 0.72 (0.31–1.71) | 0.7 | 1.12 (0.50–2.41) | 0.7 | ||||
| Serum sodium | 0.97 (0.88–1.07) | 0.6 | 1.06 (0.95–1.1) | 0.2 | ||||
| Arm (Rifaximin vs. norfloxacin) | 0.52 (0.135–2.037) | 0.3 | 0.40 (0.09–1.75) | 0.2 | 0.14 (0.02–0.72) | 0.02 | 0.14 (0.02–0.73) | 0.02 |
| Ascitic fluid protein | 0.65 (0.20–2.08) | 0.4 | 1.32 (0.64–2.72) | 0.4 | ||||
| CTP | 0.7 (0.46–1.33) | 0.4 | 0.97 (0.65–1.46) | 0.8 | ||||
| MELD | 1.1 (1.01–1.19) | 0.02 | 1.11 (1.01–1.21) | 0.02 | 0.97 (0.87–1.085) | 0.6 | 0.97 (0.87–1.085) | 0.6 |
CTP, Child Turcotte Pugh; MELD, Model for end-stage liver disease; OR, Odds ratio.